Tempus AI, a Chicago-based provider of data and analytics tools for precision medicine, raised $411 million in its IPO, pricing at the top of its $35-$37 range and achieving a market value exceeding $6 billion. The company’s largest shareholder is founder and CEO Eric Lefkofsky, also known for co-founding Groupon. Tempus, backed by investors like Baillie Gifford and NEA, claims to have the world’s largest library of clinical and molecular data to aid healthcare providers in patient care.
Per Fierce Healthcare: “Tempus says it’s built the world’s largest library of clinical and molecular data along with an operating system to make those data accessible and useful for providers to inform patient care.”
